Intest Res Search

CLOSE


Ahead-of Print

  • HOME
  • BROWSE ARTICLES
  • Ahead-of Print

Articles in E-pub version are posted online ahead of regular printed publication.

Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale
Received July 19, 2022  Accepted August 30, 2022  
DOI: https://doi.org/10.5217/ir.2022.00094    [Epub ahead of print]
PDF    
Close layer
prev next
Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
Received July 17, 2022  Accepted August 25, 2022  
DOI: https://doi.org/10.5217/ir.2022.00092    [Epub ahead of print]
PDF    
Close layer
prev next
Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood
Received July 9, 2022  Accepted September 19, 2022  
DOI: https://doi.org/10.5217/ir.2022.00087    [Epub ahead of print]
PDF    
Close layer
prev next
Laparoscopic surgery contributes to a decrease in short-term complications in surgical ulcerative colitis patients during 2008–2017: a multicenter retrospective study in China
Zerong Cai, Xiaosheng He, Jianfeng Gong, Peng Du, Wenjian Meng, Wei Zhou, Jinbo Jiang, Bin Wu, Weitang Yuan, Qi Xue, Lianwen Yuan, Jinhai Wang, Jiandong Tai, Jie Liang, Weiming Zhu, Ping Lan, Xiaojian Wu
Received January 21, 2022  Accepted April 1, 2022  
DOI: https://doi.org/10.5217/ir.2022.00012    [Epub ahead of print]
PDF    
Close layer
prev next
Anti-inflammatory properties of butyrate-producing atypical Escherichia coli in a murine colitis model
Ji Hyung Kim, Jee In Yoo, Hyun Woo Ma, I Seul Park, Mijeong Son, Yoojin Shin, Ki Beom Kim, Seung Won Kim, Si Jae Park, Jihye Park
Received September 6, 2022  Accepted September 22, 2022  
DOI: https://doi.org/10.5217/ir.2022.00112    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
The role and prospect of tofacitinib in patients with ulcerative colitis
Jun Lee
Received July 26, 2022  Accepted August 27, 2022  
DOI: https://doi.org/10.5217/ir.2022.00098    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
Received August 3, 2021  Accepted November 16, 2021  
DOI: https://doi.org/10.5217/ir.2021.00110    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
Arshdeep Singh, Yogesh Kumar Gupta, Ashvin Singh Dhaliwal, Bhavjeet Kaur Kahlon, Vasu Bansal, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Ramandeep Kaur, Namita Bansal, Vandana Midha, Ajit Sood
Received March 23, 2022  Accepted June 29, 2022  
DOI: https://doi.org/10.5217/ir.2022.00037    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, Byong Duk Ye, Kyeong Ok Kim, Jeong Eun Shin, Yong Sik Yoon, Hong Sub Lee, Sung Hoon Jung, Miyoung Choi, Soo-Young Na, Chang Hwan Choi, Joo Sung Kim, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Received February 21, 2022  Accepted April 18, 2022  
DOI: https://doi.org/10.5217/ir.2022.00029    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease
Yu Kyung Jun, Hyuk Yoon, Seong-Joon Koh, A Hyeon Kim, Kwang Woo Kim, Jun Won Park, Hyun Jung Lee, Hyoun Woo Kang, Jong Pil Im, Young Soo Park, Joo Sung Kim, on behalf of Seoul National University Inflammatory Bowel Disease Research Network (SIRN)
Received April 22, 2022  Accepted June 10, 2022  
DOI: https://doi.org/10.5217/ir.2022.00057    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Proposal of novel staging system CNM (Crohn’s primary site, nodes, mesentery) to predict postoperative recurrence of Crohn’s disease
Guduru Venkat Rao, Partha Pal, Anuradha Sekaran, Pradeep Rebala, Manu Tandan, D. Nageshwar Reddy
Received April 1, 2022  Accepted June 6, 2022  
DOI: https://doi.org/10.5217/ir.2022.00045    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Clinical spectrum of elderly-onset inflammatory bowel disease in India
Yogesh Kumar Gupta, Arshdeep Singh, Vikram Narang, Vandana Midha, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Namita Bansal, Madeline Vithya Barnaba Durairaj, Amit Kumar Dutta, Ajit Sood
Received December 27, 2021  Accepted May 17, 2022  
DOI: https://doi.org/10.5217/ir.2021.00177    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Characteristics and usefulness of transabdominal ultrasonography in immune-mediated colitis
Kensuke Sakurai, Takehiko Katsurada, Mutsumi Nishida, Satomi Omotehara, Shinya Fukushima, Shinsuke Otagiri, Kazunori Nagashima, Reizo Onishi, Ryo Takagi, Yoshito Komatsu, Naoya Sakamoto
Received December 3, 2021  Accepted June 6, 2022  
DOI: https://doi.org/10.5217/ir.2021.00166    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study
Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye, on behalf of the Korean Association for the Study of Intestinal Diseases
Received December 23, 2021  Accepted February 14, 2022  
DOI: https://doi.org/10.5217/ir.2021.00173    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Reviewing not Homer’s Iliad, but “Kai Bao Ben Cao”: indigo dye—the past, present, and future
Yusuke Yoshimatsu, Tomohisa Sujino, Takanori Kanai
Received February 7, 2022  Accepted April 23, 2022  
DOI: https://doi.org/10.5217/ir.2022.00018    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Received December 10, 2021  Accepted March 10, 2022  
DOI: https://doi.org/10.5217/ir.2021.00168    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
Karan Sachdeva, Peeyush Kumar, Bhaskar Kante, Sudheer K. Vuyyuru, Srikant Mohta, Mukesh K. Ranjan, Mukesh K. Singh, Mahak Verma, Govind Makharia, Saurabh Kedia, Vineet Ahuja
Received January 18, 2022  Accepted March 27, 2022  
DOI: https://doi.org/10.5217/ir.2022.00010    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, On behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Received January 16, 2021  Accepted March 7, 2022  
DOI: https://doi.org/10.5217/ir.2022.00007    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
An Asian perspective on irritable bowel syndrome
Kee Wook Jung, Seung-Jae Myung
Received October 5, 2021  Accepted January 16, 2022  
DOI: https://doi.org/10.5217/ir.2021.00136    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
Jae Hee Cheon, Kristine Paridaens, Sameer Al Awadhi, Jakob Begun, John R Fullarton, Edouard Louis, Fernando Magro, Juan Ricardo Marquez, Alexander R Moschen, Neeraj Narula, Grazyna Rydzewska, Axel U Dignass, Simon PL Travis
Received January 10, 2022  Accepted March 16, 2022  
DOI: https://doi.org/10.5217/ir.2022.00006    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Incidence rates for hospitalized infections, herpes zoster, and malignancies in patients with ulcerative colitis in Japan: an administrative health claims database analysis
Katsuyoshi Matsuoka, Kanae Togo, Noritoshi Yoshii, Masato Hoshi, Shoko Arai
Received November 3, 2021  Accepted January 17, 2022  
DOI: https://doi.org/10.5217/ir.2021.00154    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe
Received October 21, 2021  Accepted December 31, 2021  
DOI: https://doi.org/10.5217/ir.2021.00143    [Epub ahead of print]
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2022 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next